Shenyang Kangzhi Pharmaceutical Co., Ltd.
-
Founded in:
1979-11-08 -
Country:
China -
Address:
No. 7A1, Kaifa Road, Shenyang Economic and Technological Development Zone -
Tax NO.:
912101001179954513 -
Registered Funds:
12.678899 yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| FERROUS SULFATE |
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.
More
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia. |
2.8g | 7720-78-7 | 5 |
| Ascorbic Acid |
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.
More
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia. |
1g | 50-81-7 | 28 |
| Vitamin B6 |
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.
More
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia. |
25mg | 8059-24-3 | 13 |
| Vitamin B12 |
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.
More
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia. |
125microgram | 68-19-9 | 16 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ethambutol dihydrochloride |
Synthetic antibacterial anti-tuberculosis drug. It has strong activity against bacteria in the growth and reproduction stage, and has almost no effect on bacteria in the dormant stage. It has high antibacterial activity against various types of mycobacteria. There is no cross-resistance between Mycobacterium tuberculosis and other drugs. It may inhibit the metabolism of sensitive bacteria, inhibit RNA synthesis, and interfere with the protein metabolism of Mycobacterium tuberculosis, thereby causing bacterial death. In large doses, it can cause cleft palate, brain exposure, and spinal deformity in mouse experiments; it can cause mild cervical deformity in rat experiments; it can cause cyclops, short limbs, and cleft palate in rabbit experiments.
More
Synthetic antibacterial anti-tuberculosis drug. It has strong activity against bacteria in the growth and reproduction stage, and has almost no effect on bacteria in the dormant stage. It has high antibacterial activity against various types of mycobacteria. There is no cross-resistance between Mycobacterium tuberculosis and other drugs. It may inhibit the metabolism of sensitive bacteria, inhibit RNA synthesis, and interfere with the protein metabolism of Mycobacterium tuberculosis, thereby causing bacterial death. In large doses, it can cause cleft palate, brain exposure, and spinal deformity in mouse experiments; it can cause mild cervical deformity in rat experiments; it can cause cyclops, short limbs, and cleft palate in rabbit experiments. |
1070-11-7 | 13 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Metronidazole |
It has a strong antibacterial effect on most anaerobic bacteria, and the antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus, etc. In addition, it also has a strong killing effect on amoeba and Trichomonas. The bactericidal mechanism is that nitro is reduced to a cytotoxin, thereby acting on the DNA metabolism process of bacteria and promoting cell death; the anti-amoeba mechanism is to inhibit its redox reaction, causing the nitrogen chain of the protozoa to break.
More
It has a strong antibacterial effect on most anaerobic bacteria, and the antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus, etc. In addition, it also has a strong killing effect on amoeba and Trichomonas. The bactericidal mechanism is that nitro is reduced to a cytotoxin, thereby acting on the DNA metabolism process of bacteria and promoting cell death; the anti-amoeba mechanism is to inhibit its redox reaction, causing the nitrogen chain of the protozoa to break. |
443-48-1 | 39 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| ()-(1R,2S)-1,2-Epoxypropyl phosphate calcium salt monohydrate |
It has antibacterial effect on most Gram-positive and Gram-negative bacteria, and inhibits the early synthesis of bacterial cell walls, thereby blocking the synthesis of bacterial cell walls and causing their death.
More
It has antibacterial effect on most Gram-positive and Gram-negative bacteria, and inhibits the early synthesis of bacterial cell walls, thereby blocking the synthesis of bacterial cell walls and causing their death. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| ()-(1R,2S)-1,2-Epoxypropyl phosphate calcium salt monohydrate |
This product has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria, and inhibits the early synthesis of bacterial cell walls, which blocks the synthesis of bacterial cell walls and leads to their death. The antibacterial spectrum includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes.
More
This product has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria, and inhibits the early synthesis of bacterial cell walls, which blocks the synthesis of bacterial cell walls and leads to their death. The antibacterial spectrum includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes. |
0 | ||
| (1R, 2S)-1,2-Epoxypropyl phosphate calcium salt monohydrate |
It has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria, and inhibits the early synthesis of bacterial cell walls, which blocks the synthesis of bacterial cell walls and leads to their death. The antibacterial spectrum includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes.
More
It has a certain antibacterial effect on most Gram-positive and Gram-negative bacteria, and inhibits the early synthesis of bacterial cell walls, which blocks the synthesis of bacterial cell walls and leads to their death. The antibacterial spectrum includes Staphylococcus aureus, Escherichia coli, Shigella, Serratia, Shigella, Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter aerogenes. |
0 |